Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Exploring the evolution of multidrug resistance patterns in ESKAPEE pathogens using association mining: Key to antibiotic stewardship? [version 3; peer review: 3 approved with reservations]

Дата публикации: 17-07-2026 09:54:14

Background Shared Multidrug resistance (sMDR) is a major challenge in antimicrobial therapy, particularly among ESKAPEE pathogens, as these bacteria develop resistance to multiple antimicrobial agents via mutations, recombination, or gene transfer. These antimicrobial resistance (AMR) mechanisms evolve and require constant surveillance. Understanding sMDR patterns in large antimicrobial surveillance datasets is complex because of the multifaceted nature of the data. Methods We explored Pfizer-Atlas (2004 – 2022) and Venatorx-GEARS (2018-2022) datasets from the Vivli platform, focusing on ESKAPEE pathogens. Descriptive data analysis, time-trend analysis, and association rule generation through the Apriori algorithm were performed using Python 3.10 libraries pandas, matplotlib, seaborn, scipy.stats, and mlxtend libraries. The best rule set that explored sMDR patterns was visualized in a network format using NetworkX: 3.2 package. Results “MERIT- Multidrug ESKAPEE Resistance Insights and Tracker” dashboard was created for user-friendly visualization of antimicrobial surveillance datasets, trends in antimicrobial susceptibility profile (ASP) over years, interactive widgets to see the ASP by country and by pathogens, and Network to see significant rules as a result of association rule mining in categories by age, year and country. Conclusion Time trend analysis revealed a decline in meropenem and piperacillin-tazobactam resistance to Enterococcus faecium and doripenem for Pseudomonas aeruginosa, while resistance to imipenem (Klebsiella pneumoniae, Acinetobacter baumannii, and Enterobacter species) and meropenem (Staphylococcus aureus, A. baumannii, and Enterobacter species) increased. Association rule mining identified sMDR patterns, such as meropenem and levofloxacin resistance, in S. aureus, K. pneumoniae, P. aeruginosa and A. baumannii. Thus, our findings from the data challenge represents hypothesis driven patterns intended to promote further investigation and clinical validation which potentially supports antibiotic stewardship efforts.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Integrating GIS and Genomics for AMR One Health Drug Target Discovery in Imipenem-Resistant Escherichia coli [version 3; peer review: 1 approved, 1 not approved]012.0910-07-2026
2A protocol for the TRACS-Liverpool study, tracking transmission of extended-spectrum beta-lactamase producing Enterobacterales across health and social care settings in the United Kingdom [version 1; peer review: 1 approved]010.7213-07-2026
3New screening tool spots RNA-disrupting antibiotics for drug-resistant gram-negative bacteria5707-07-2026
4Sero-epidemiological studies of pathogen burden: A scoping review [version 3; peer review: 2 approved, 1 approved with reservations]08.9811-07-2026
5Living mapping review of global research funding for pandemic-prone infectious diseases– Pandemic PACT Grant Tracker [version 2; peer review: 2 approved with reservations]08.0606-07-2026
6ВОЗ: устойчивость микробов к антибиотикам может свести на нет успехи медицины за столетие0019-06-2019
7ВОЗ обеспокоена медленной разработкой новых антибиотиков0020-01-2020
8Pedagogies of Participation and Epistemic Justice: Applying the Pathfinder Methodology in the Colombian Amazonian Piedmont [version 2; peer review: 1 approved, 1 approved with reservations]09.5827-07-2026
9Social and behavioural evidence for community protection in Public Health Emergencies: a scoping review and landscape analysis [version 1; peer review: awaiting peer review]07.3423-07-2026
10A phase I double-blind, placebo-controlled (Part B only), randomised trial to evaluate the safety, tolerability, and pharmacokinetics of single dose in fed state, and repeat doses of DNDI-6899 in healthy participants [version 1; peer review: awaiting peer review]09.3810-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 10.12. Источник: wellcomeopenresearch.org.